31:
177:. In 2005, she returned to the Karolinska Institute, where she continued to study the epidemiology of cancer. Her research considers women's health, with a particular focus on identifying risk factors for certain forms of cancer. She was responsible for the Ugandan Collaboration of Infectious Diseases. Weiderpass found several lifestyle risk factors, such as tobacco use, diet and obesity, can have a marked impact on a person's likelihood to suffer from cancer.
239:
144:
in south Brazil. During her undergraduate degree, Weiderpass became increasingly interested in epidemiology and public health. She remained at the
Federal University of Pelotas for her graduate studies, where she completed a master's degree in epidemiology. Weiderpass moved to the
390:"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015"
169:. These experiences inspired a career focused on reducing inequalities in cancer diagnosis and treatment. She developed and delivered training programmes for African medical doctors and researchers. Her students included
135:
she explained that she grew up in a working-class family, and that it was unclear whether or not she would attend university. Her parents encouraged her to continue her studies, and she was approved to study
534:
329:"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013"
968:
184:, where she spent over ten years. At the same time, she oversaw the Cancer Registry of Norway, which is located in the Institute of Population-based Cancer Research in
983:
973:
767:
166:
110:
68:
792:
208:
978:
207:, which provides an overview of current cancer research and information on strategies for cancer prevention. She partnered with the
141:
49:
211:
in 2020, working together to deliver a series of webinars and e-learning modules focussed on the elimination of cancer.
76:
126:
963:
589:
199:
Weiderpass was elected
Director of the International Agency for Research on Cancer in 2019. The agency is based in
114:
861:
535:"Egressa da UFPel será primeira mulher a assumir a direção da Agência Internacional para Pesquisa em Câncer"
193:
189:
174:
30:
958:
495:
471:
180:
In 2007, Weiderpass was made Head of the
Genetic Epidemiology Group at the Folkhälsan Research Center in
272:
644:
263:
146:
72:
768:"Dr Elisabete Weiderpass presents World Cancer Report: Cancer Research for Cancer Prevention – IARC"
248:
626:
437:
162:
150:
926:
695:
268:"Heart disease and stroke statistics--2012 update: a report from the American Heart Association"
819:
618:
610:
566:
475:
429:
411:
368:
350:
307:
289:
602:
445:
419:
403:
376:
358:
342:
315:
297:
281:
844:"100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023"
743:
917:
885:
244:
921:
467:
463:
424:
389:
388:
Mohammad H Forouzanfar; Ashkan Afshin; Lily T Alexander; et al. (1 October 2016).
363:
328:
302:
267:
223:
2017 Gansu
Foreign Experts Administration Dunhuang Award for Outstanding Foreign Expert
606:
407:
346:
952:
630:
939:
441:
170:
285:
203:. Weiderpass is the first woman to hold the position. In 2020, she launched the
394:
333:
131:
614:
570:
415:
354:
293:
843:
226:
2023 Recognized as one of the 100 Influential Women in
Oncology by OncoDaily
719:
622:
433:
372:
311:
560:
449:
380:
319:
181:
137:
89:
327:
Marie Ng; Tom
Fleming; Margaret Robinson; et al. (30 August 2014).
496:"Preventing cancer in all corners of the world | Karolinska Institutet"
943:
930:
83:
671:
117:. Her research considers the epidemiology and prevention of cancer.
793:"ESMO and IARC Join Forces to Improve Cancer Prevention Worldwide"
200:
185:
220:
2017 Elected Fellow of the
European Academy of Cancer Sciences
149:
for her doctoral studies, where she studied the aetiology of
562:
Some hormonal factors in the etiology of endometrial cancer
90:
Some hormonal factors in the etiology of endometrial cancer
862:"IARC Governing Council elects new IARC Director | UICC"
109:
is a
Brazilian cancer researcher who is Director of the
266:; Go AS; Lloyd-Jones DM; et al. (3 January 2012).
590:"Elisabete Weiderpass: charting a new course for IARC"
82:
64:
45:
37:
21:
588:
161:In the early 2000s, Weiderpass started to work in
8:
672:"Elisabete Weiderpass Vainio | Medarbetare"
167:International Agency for Research on Cancer
111:International Agency for Research on Cancer
69:International Agency for Research on Cancer
29:
18:
423:
362:
301:
41:1965 or 1966 (age 57–58)
173:, who went on to become Director of the
984:21st-century Brazilian women scientists
696:"Biography Elisabete Weiderpass | UICC"
487:
814:
812:
209:European Society for Medical Oncology
7:
974:Federal University of Pelotas alumni
666:
664:
582:
580:
529:
527:
525:
523:
521:
519:
517:
515:
927:Elisabete Weiderpass's publications
969:People from Santo André, São Paulo
14:
645:"Part I: Cancer's Lonely Soldier"
539:Coordenação de Comunicação Social
237:
886:"Elisabete_Weiderpass - USERN"
587:Davies, Rachael (2019-04-27).
559:Weiderpass, Elisabete (1999).
1:
820:"Elisabete Weiderpass – IARC"
607:10.1016/S0140-6736(19)30866-9
408:10.1016/S0140-6736(16)31679-8
347:10.1016/S0140-6736(14)60460-8
142:Federal University of Pelotas
50:Federal University of Pelotas
462:Weiderpass is a naturalised
286:10.1161/CIR.0B013E31823AC046
77:Yale School of Public Health
979:Karolinska Institute alumni
720:"About the Director – IARC"
470:citizen. She is married to
107:Elisabete Weiderpass-Vainio
16:Brazilian cancer researcher
1000:
541:(in Brazilian Portuguese)
115:World Health Organization
100:
57:
28:
933:bibliographic database.
920:publications indexed by
121:Early life and education
935:(subscription required)
912:Bibliographic databases
194:Yale School of Medicine
175:Uganda Cancer Institute
129:. In an interview with
744:"Elisabete Weiderpass"
127:Santo André, São Paulo
565:(Thesis). Stockholm.
250:Elisabete Weiderpass
940:Elisabete Weiderpass
918:Elisabete Weiderpass
402:(10053): 1659–1724.
190:University of Tromsø
188:, as well as at the
147:Karolinska Institute
73:Karolinska Institute
53:Karolinska Institute
23:Elisabete Weiderpass
472:Harri Uolevi Vainio
231:Select publications
205:World Cancer Report
157:Research and career
125:Weiderpass is from
964:Cancer researchers
649:The World from PRX
247:has a profile for
215:Awards and honours
163:Sub-Saharan Africa
151:endometrial cancer
748:medicine.yale.edu
476:Kuwait University
474:, a professor at
341:(9945): 766–781.
253:
104:
103:
59:Scientific career
991:
936:
900:
899:
897:
896:
890:usern.tums.ac.ir
882:
876:
875:
873:
872:
858:
852:
851:
840:
834:
833:
831:
830:
824:www.iarc.who.int
816:
807:
806:
804:
803:
788:
782:
781:
779:
778:
772:www.iarc.who.int
764:
758:
757:
755:
754:
740:
734:
733:
731:
730:
724:www.iarc.who.int
716:
710:
709:
707:
706:
692:
686:
685:
683:
682:
668:
659:
658:
656:
655:
641:
635:
634:
592:
584:
575:
574:
556:
550:
549:
547:
546:
531:
510:
509:
507:
506:
492:
453:
427:
384:
366:
323:
305:
251:
241:
240:
113:, a part of the
96:
33:
19:
999:
998:
994:
993:
992:
990:
989:
988:
949:
948:
934:
929:indexed by the
914:
909:
904:
903:
894:
892:
884:
883:
879:
870:
868:
860:
859:
855:
842:
841:
837:
828:
826:
818:
817:
810:
801:
799:
790:
789:
785:
776:
774:
766:
765:
761:
752:
750:
742:
741:
737:
728:
726:
718:
717:
713:
704:
702:
694:
693:
689:
680:
678:
670:
669:
662:
653:
651:
643:
642:
638:
601:(10182): 1689.
586:
585:
578:
558:
557:
553:
544:
542:
533:
532:
513:
504:
502:
494:
493:
489:
484:
460:
387:
326:
262:
259:
258:
257:
242:
238:
233:
217:
159:
123:
94:
75:
71:
52:
46:Alma mater
24:
17:
12:
11:
5:
997:
995:
987:
986:
981:
976:
971:
966:
961:
951:
950:
947:
946:
937:
924:
922:Google Scholar
913:
910:
908:
907:External links
905:
902:
901:
877:
853:
835:
808:
783:
759:
735:
711:
687:
660:
636:
576:
551:
511:
486:
485:
483:
480:
459:
456:
455:
454:
385:
324:
280:(1): e2–e220.
243:
236:
235:
234:
232:
229:
228:
227:
224:
221:
216:
213:
158:
155:
122:
119:
102:
101:
98:
97:
86:
80:
79:
66:
62:
61:
55:
54:
47:
43:
42:
39:
35:
34:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
996:
985:
982:
980:
977:
975:
972:
970:
967:
965:
962:
960:
959:Living people
957:
956:
954:
945:
941:
938:
932:
928:
925:
923:
919:
916:
915:
911:
906:
891:
887:
881:
878:
867:
863:
857:
854:
849:
845:
839:
836:
825:
821:
815:
813:
809:
798:
794:
787:
784:
773:
769:
763:
760:
749:
745:
739:
736:
725:
721:
715:
712:
701:
697:
691:
688:
677:
673:
667:
665:
661:
650:
646:
640:
637:
632:
628:
624:
620:
616:
612:
608:
604:
600:
596:
591:
583:
581:
577:
572:
568:
564:
563:
555:
552:
540:
536:
530:
528:
526:
524:
522:
520:
518:
516:
512:
501:
497:
491:
488:
481:
479:
477:
473:
469:
465:
458:Personal life
457:
451:
447:
443:
439:
435:
431:
426:
421:
417:
413:
409:
405:
401:
397:
396:
391:
386:
382:
378:
374:
370:
365:
360:
356:
352:
348:
344:
340:
336:
335:
330:
325:
321:
317:
313:
309:
304:
299:
295:
291:
287:
283:
279:
275:
274:
269:
265:
261:
260:
255:
254:
246:
230:
225:
222:
219:
218:
214:
212:
210:
206:
202:
197:
195:
191:
187:
183:
178:
176:
172:
168:
164:
156:
154:
152:
148:
143:
139:
134:
133:
128:
120:
118:
116:
112:
108:
99:
92:
91:
87:
85:
81:
78:
74:
70:
67:
63:
60:
56:
51:
48:
44:
40:
36:
32:
27:
20:
893:. Retrieved
889:
880:
869:. Retrieved
866:www.uicc.org
865:
856:
847:
838:
827:. Retrieved
823:
800:. Retrieved
797:www.esmo.org
796:
786:
775:. Retrieved
771:
762:
751:. Retrieved
747:
738:
727:. Retrieved
723:
714:
703:. Retrieved
700:www.uicc.org
699:
690:
679:. Retrieved
675:
652:. Retrieved
648:
639:
598:
594:
561:
554:
543:. Retrieved
538:
503:. Retrieved
499:
490:
461:
399:
393:
338:
332:
277:
271:
249:
204:
198:
179:
171:Jackson Orem
160:
130:
124:
106:
105:
88:
65:Institutions
58:
676:staff.ki.se
273:Circulation
252:(Q28606966)
953:Categories
895:2021-01-29
871:2021-01-29
829:2021-01-29
802:2021-01-29
777:2021-01-29
753:2021-01-29
729:2021-01-29
705:2021-01-29
681:2021-01-29
654:2021-01-29
595:The Lancet
545:2021-01-29
505:2022-07-30
482:References
395:The Lancet
334:The Lancet
132:The Lancet
848:OncoDaily
631:205990613
615:0140-6736
571:186951765
450:Q30353195
416:0140-6736
381:Q29616834
355:0140-6736
320:Q29547909
294:0009-7322
165:with the
623:31034367
446:Wikidata
442:13770184
434:27733284
377:Wikidata
373:24880830
316:Wikidata
312:22179539
264:Roger VL
182:Helsinki
138:medicine
468:Finnish
464:Swedish
425:5388856
364:4624264
303:4440543
245:Scholia
140:at the
944:PubMed
931:Scopus
791:ESMO.
629:
621:
613:
569:
448:
440:
432:
422:
414:
379:
371:
361:
353:
318:
310:
300:
292:
95:(1999)
93:
84:Thesis
627:S2CID
500:ki.se
438:S2CID
619:PMID
611:ISSN
567:OCLC
466:and
430:PMID
412:ISSN
369:PMID
351:ISSN
308:PMID
290:ISSN
201:Lyon
192:and
186:Oslo
38:Born
942:at
603:doi
599:393
420:PMC
404:doi
400:388
359:PMC
343:doi
339:384
298:PMC
282:doi
278:125
955::
888:.
864:.
846:.
822:.
811:^
795:.
770:.
746:.
722:.
698:.
674:.
663:^
647:.
625:.
617:.
609:.
597:.
593:.
579:^
537:.
514:^
498:.
478:.
444:.
436:.
428:.
418:.
410:.
398:.
392:.
375:.
367:.
357:.
349:.
337:.
331:.
314:.
306:.
296:.
288:.
276:.
270:.
196:.
153:.
898:.
874:.
850:.
832:.
805:.
780:.
756:.
732:.
708:.
684:.
657:.
633:.
605::
573:.
548:.
508:.
452:.
406::
383:.
345::
322:.
284::
256:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
